Unicycive Therapeutics Inc (UNCY) is lower by 6.33% Wednesday In Premarket Trading

Unicycive Therapeutics Inc (UNCY) has fallen Wednesday morning, with the stock declining -6.33% in pre-market trading to 2.07. UNCY's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, UNCY ranks higher than 99% of stocks. Unicycive Therapeutics Inc has risen 301.82% over the past month, closing at $0.56 on February 15. During this period of time, the stock fell as low as $0.47 and as high as $2.87. UNCY has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.

UNCY has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on UNCY!

See Full UNCY Report

Unicycive Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 124 by this metric, UNCY ranks better than 124% of stocks.

Important Dates for Investors in UNCY:

-Unicycive Therapeutics Inc is set to release earnings on 3/30/2023. Over the last 12 months, the company has reported EPS of $-1.02. -We do not have a set dividend date for Unicycive Therapeutics Inc at this time. Click Here To Get The Full Report on Unicycive Therapeutics Inc (UNCY)